Ever since President Donald Trump started promising to slap tariffs on pharmaceutical imports, drugmakers have unveiled a ...

Pfizer CEO Albert Bourla is expected at a pro-Trump fundraiser on Friday, sources told CBS News, one day after the president ...

Measures laid out in letters to 17 companies would either have modest impact or face legal challenges, say industry experts.

He said if they didn't, the US would deploy 'every tool in our arsenal' to protect families from 'continued abusive drug ...

AstraZeneca already sells 40 per cent of its drugs to America and, following President Donald Trump 's tariff threat, is ...

President Trump's latest trade salvo brought risk aversion back to the FTSE 100 index today as AstraZeneca fell sharply and ...

DONALD Trump insists he will unleash “every tool in our arsenal” if British drug companies don’t cut their prices within 60 ...

Pfizer CEO Albert Bourla is expected to attend a $25 million fundraiser at US President Donald Trump’s golf club in ...

Bristol-Myers Squibb Company beats revenue forecasts & raises 2025 guidance. Click for key BMY catalysts, risks, and outlook ...

President Trump sent letters to major drug companies, urging them to lower U.S. medicine prices to match international rates.

On July 31, the Trump administration told 17 major drugmakers to align U.S. medication prices with the lowest prices sold in other countries, or the most-favored-nation price.  The White House ...

Experts are skeptical that Big Pharma companies will cut prices after President Donald Trump demands Most Favored Nation policies within 60 days.